Go to deals
Healthcare

First Coast Mohs has been acquired by AQUA Dermatology

Dermatology and skin cancer specialist First Coast Mohs has partnered with AQUA Dermatology.

First Coast Mohs offers Mohs surgery, surgical and medical dermatology, dermatopathology, cosmetic and laser treatments, electrolysis and other aesthetic services from four state-of-the-art facilities in metro Jacksonville, Florida. The practice features seven clinicians, including two Mohs surgeons, two board certified dermatologists and three Advanced Practice Providers. First Coast Mohs was founded in 2002 by Dr. Scott Warren, who will continue to lead the practice following the transaction.

AQUA Dermatology, backed by Gryphon Investors and GTCR, is the largest dermatology practice in the southeastern United States with over 110 locations and 250 providers. For more than 25 years, the company has treated patients of all ages suffering from skin diseases, acne, sun damage, skin cancer and vein health issues as well as those seeking cosmetic and plastic surgery. With First Coast Mohs, AQUA Dermatology now has 78 locations in Florida.

Oaklins Heritage in Jacksonville served as the intermediary and exclusive financial advisor to the seller in this transaction.

Parties
“The Oaklins Heritage team helped me far beyond my expectations. Their expertise in all aspects of the process, from start to finish, was very detailed and all-encompassing.”

Dr. Scott Warren

Owner, First Coast Mohs

Talk to the deal team

Daniel Edelman

Principal
Jacksonville, United States
Oaklins Heritage

Dan Curran

Principal
Jacksonville, United States
Oaklins Heritage

Alex Kellison

Principal
Jacksonville, United States
Oaklins Heritage

Mike Bouton

Senior Analyst
Jacksonville, United States
Oaklins Heritage

Related deals

Bayer AG has entered into a takeover agreement with Cara Care
Healthcare | TMT

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

Learn more
Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
Healthcare

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.

Learn more
Creo Medical Group plc has completed a US$15.7 million equity fundraise
Healthcare

Creo Medical Group plc has completed a US$15.7 million equity fundraise

Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.

Learn more